Cigna (CI) Q2 Revenue Jumps 11%
Werte in diesem Artikel
Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company reported headline financial results (non-GAAP) that outpaced analyst expectations, with revenue climbed to $67.2 billion and adjusted diluted EPS was $7.20. Analysts had expected adjusted EPS (non-GAAP) of $7.16 and revenue of $62,571.45 million. The quarter featured broad-based revenue growth, driven by the Evernorth Health Services platform, though overall profit margins moderated and the company faced shifts in customer mix due to the divestiture of Medicare-related businesses. Overall, the period showed strong execution and ongoing investment in innovation across the enterprise. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Cigna Group is organized around two primary business platforms: Evernorth Health Services, which provides pharmacy benefit services and specialty care, and Cigna Healthcare, which offers medical insurance plans in the U.S. and globally. By leveraging both platforms, the company aims to deliver integrated solutions across medical, pharmacy, and specialty categories. This dual-structure enables it to address the unique needs of diverse customer groups, from large employers to individual members.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Q2
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: MotleyFool
Nachrichten zu The Cigna Group Registered Shs
Analysen zu The Cigna Group Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
20.07.2018 | Express Scripts Neutral | Robert W. Baird & Co. Incorporated | |
08.03.2018 | Express Scripts Equal Weight | Barclays Capital | |
08.03.2018 | Cigna Overweight | Barclays Capital | |
31.01.2018 | Express Scripts Outperform | RBC Capital Markets | |
15.12.2017 | Express Scripts Outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cigna Overweight | Barclays Capital | |
31.01.2018 | Express Scripts Outperform | RBC Capital Markets | |
15.12.2017 | Express Scripts Outperform | Robert W. Baird & Co. Incorporated | |
14.12.2017 | Express Scripts Buy | Maxim Group | |
04.12.2017 | Express Scripts Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
20.07.2018 | Express Scripts Neutral | Robert W. Baird & Co. Incorporated | |
08.03.2018 | Express Scripts Equal Weight | Barclays Capital | |
19.09.2017 | Express Scripts Sector Perform | RBC Capital Markets | |
21.07.2017 | Express Scripts Hold | Needham & Company, LLC | |
26.04.2017 | Express Scripts Hold | Edward Jones |
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2016 | Express Scripts Sell | Deutsche Bank AG | |
13.01.2009 | CIGNA sell | Citigroup Corp. | |
07.11.2007 | CIGNA underweight | Lehman Brothers Inc. | |
02.11.2006 | Update CIGNA Corp.: Underweight | Lehman Brothers |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen